Executive Director
AstraZeneca
Weston, Massachusetts
Annette Bak, Ph.D., MBA leads Advanced Drug Delivery (ADD), Astra Zeneca and serves on the Pharmaceutical Sciences leadership team. ADD has the mission to transform diverse modalities into investigational medicines and is a global organization based in Sweden, UK, and US.
Since joining AstraZeneca in 2016, Annette has been instrumental in delivering a variety of synthetic modality and mRNA drug delivery systems and formulations for preclinical & clinical studies. She has also built delivery chemistry and intracellular drug delivery capabilities within ADD.
Annette previously worked for Amgen and Merck in the US with responsibility for small molecule and peptide formulations.
She has published more than 50 articles, and has more than 50 invited presentations.She holds several patents for pharmaceutical technologies enabling drug delivery of small molecules and biologics.
A key volunteer in American Association of Pharmaceutical Scientists (AAPS). She was the 2022 president and responsible for leading the 2021-2025 strategic plan and ensuring that the AAPS communities are thriving. Annette was the 2020 co-recipient of the AAPS Alice E Till Women in Pharmaceutical Science Recognition, honoring women who has made significant contributions to the to the mentorship and advancement of women in the pharmaceutical sciences.
Disclosure information not submitted.
Roadmap to Designing and Selecting LNPs for mRNA Drug Delivery
Wednesday, October 23, 2024
9:00 AM – 9:30 AM MT
Wednesday, October 23, 2024
11:30 AM – 12:25 PM MT